BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Trifan A, Stoica O, Stanciu C, Cojocariu C, Singeap AM, Girleanu I, Miftode E. Clostridium difficile infection in patients with liver disease: a review. Eur J Clin Microbiol Infect Dis 2015;34:2313-24. [PMID: 26440041 DOI: 10.1007/s10096-015-2501-z] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kouzegaran S, Ganjifard M, Tanha AS. DETECTION, RIBOTYPING AND ANTIMICROBIAL RESISTANCE PROPERTIES OF CLOSTRIDIUM DIFFICILE STRAINS ISOLATED FROM THE CASES OF DIARRHEA. Mater Sociomed 2016;28:324-8. [PMID: 27999477 DOI: 10.5455/msm.2016.28.324-328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
2 Yan D, Huang Y, Chen Y, Lv T, Gu S, Li Y, Huang J, Li L. Risk factors for Clostridium difficile infection in cirrhotic patients. Hepatobiliary & Pancreatic Diseases International 2019;18:237-41. [DOI: 10.1016/j.hbpd.2019.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Pringle PL, Soto MT, Chung RT, Hohmann E. Patients With Cirrhosis Require More Fecal Microbiota Capsules to Cure Refractory and Recurrent Clostridium difficile Infections. Clin Gastroenterol Hepatol. 2019;17:791-793. [PMID: 29859984 DOI: 10.1016/j.cgh.2018.05.038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
4 Wijarnpreecha K, Aby ES, Kim D, Ungprasert P, Cheungpasitporn W, Thongprayoon C, Lukens FJ, Harnois DM, Kröner PT. The burden of Clostridioides difficile infection in patients with history of liver transplant and during index admission. Eur J Gastroenterol Hepatol 2021;33:894-8. [PMID: 32541243 DOI: 10.1097/MEG.0000000000001812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kriss M, Hazleton KZ, Nusbacher NM, Martin CG, Lozupone CA. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34-40. [PMID: 30036705 DOI: 10.1016/j.mib.2018.07.003] [Cited by in Crossref: 105] [Cited by in F6Publishing: 96] [Article Influence: 26.3] [Reference Citation Analysis]
6 Qu J, Zhao Y, Yin J. Identification and Analysis of Human Microbe-Disease Associations by Matrix Decomposition and Label Propagation. Front Microbiol 2019;10:291. [PMID: 30863376 DOI: 10.3389/fmicb.2019.00291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Chen Y, Gui Q, Xu Q, Lv T, Gu S, Shen P, Quan J, Fang Y, Ye G, Li L. Clostridium difficile Infection Among Hospitalized Chronic Hepatitis B Virus-Infected Patients in a Chinese Hospital. Jundishapur J Microbiol 2018;11. [DOI: 10.5812/jjm.68809] [Reference Citation Analysis]
8 Verna EC, Pereira MR. Transplanting patients with active bacterial infection. Clin Liver Dis (Hoboken) 2017;9:81-5. [PMID: 30992965 DOI: 10.1002/cld.624] [Reference Citation Analysis]
9 Ramos-Martínez A, Serrano-Martínez F, Pintos I, Valencia-Alijo Á, Gutiérrez-Rojas Á, Cítores MJ, Ortiz-Balbuena J, Royuela A, Martínez-Ruiz R, Sánchez-Romero I, Asensio Á, Múñez E, Plaza A. Effective definition of low humoral response to Clostridioides difficile infection. Anaerobe 2021;72:102475. [PMID: 34752901 DOI: 10.1016/j.anaerobe.2021.102475] [Reference Citation Analysis]
10 Siddique O, Siddique AS, Machan JT, Promrat K. Effects of infection on post-transplant outcomes: living versus deceased donor liver transplants. Clin Exp Hepatol 2018;4:28-34. [PMID: 29594195 DOI: 10.5114/ceh.2018.73464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Miftode RS, Şerban IL, Timpau AS, Miftode IL, Ion A, Buburuz AM, Costache AD, Costache II. Syndecan-1: A Review on Its Role in Heart Failure and Chronic Liver Disease Patients' Assessment. Cardiol Res Pract 2019;2019:4750580. [PMID: 31815014 DOI: 10.1155/2019/4750580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Negrut N, Bungau S, Behl T, Khan SA, Vesa CM, Bustea C, Nistor-cseppento DC, Rus M, Pavel F, Tit DM. Risk Factors Associated with Recurrent Clostridioides difficile Infection. Healthcare 2020;8:352. [DOI: 10.3390/healthcare8030352] [Reference Citation Analysis]
13 Long B, Koyfman A. The emergency medicine evaluation and management of the patient with cirrhosis. The American Journal of Emergency Medicine 2018;36:689-98. [DOI: 10.1016/j.ajem.2017.12.047] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Voicu MN, Popescu F, Florescu DN, Rogoveanu I, Turcu-Stiolica A, Gheonea DI, Iovanescu VF, Iordache S, Cazacu SM, Ungureanu BS. Clostridioides difficile Infection among Cirrhotic Patients with Variceal Bleeding. Antibiotics (Basel) 2021;10:731. [PMID: 34204307 DOI: 10.3390/antibiotics10060731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Phatharacharukul P, Purpura RD, Gandhi D, Xu H, Bickett-Burkhart K, Chalasani N, Fischer M, Orman ES. Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. Clin Transl Gastroenterol 2020;11:e00189. [PMID: 32675703 DOI: 10.14309/ctg.0000000000000189] [Reference Citation Analysis]
16 Negrut N, Bungau S, Behl T, Khan SA, Vesa CM, Bustea C, Nistor-Cseppento DC, Rus M, Pavel FM, Tit DM. Risk Factors Associated with Recurrent Clostridioides difficile Infection. Healthcare (Basel) 2020;8:E352. [PMID: 32967323 DOI: 10.3390/healthcare8030352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kruger AJ, Durkin C, Mumtaz K, Hinton A, Krishna SG. Early Readmission Predicts Increased Mortality in Cirrhosis Patients After Clostridium difficile Infection. J Clin Gastroenterol 2019;53:e322-7. [PMID: 30045168 DOI: 10.1097/MCG.0000000000001090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Ulger Toprak N, Balkose G, Durak D, Dulundu E, Demirbaş T, Yegen C, Soyletir G. Clostridium difficile: A rare cause of pyogenic liver abscess. Anaerobe 2016;42:108-10. [PMID: 27693543 DOI: 10.1016/j.anaerobe.2016.09.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
19 Khanafer N, Vanhems P, Barbut F, Luxemburger C, Demont C, Hulin M, Dauwalder O, Vandenesch F, Argaud L, Badet L, Barth X, Bertrand M Dr., Burillon C, Chapurlat R, Chuzeville M, Comte B, Disant F, Fessy MH, Gouillat C, Juillard L, Lermusiaux P, Monneuse O, Morelon E, Ninet J, Ponchon T, Poulet E, Rimmele T, Tazarourte K; CDI01 Study group., Teams of:. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort. Anaerobe 2017;44:117-23. [PMID: 28279859 DOI: 10.1016/j.anaerobe.2017.03.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
20 Smith EZ, Northup PG, Argo CK. Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection. Journal of Clinical Gastroenterology 2018;52:747-51. [DOI: 10.1097/mcg.0000000000000868] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
21 Dotson KM, Aitken SL, Sofjan AK, Shah DN, Aparasu RR, Garey KW. Outcomes associated with Clostridium difficile infection in patients with chronic liver disease. Epidemiol Infect 2018;146:1101-5. [PMID: 29739486 DOI: 10.1017/S0950268818001036] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
22 Lee S, Lee H, Kim S, Lee J, Ha J, Choi Y, Oh H, Kim Y, Lee Y, Choi KH, Yoon Y. Intestinal Clostridioides difficile Can Cause Liver Injury through the Occurrence of Inflammation and Damage to Hepatocytes. Biomed Res Int 2020;2020:7929610. [PMID: 33005688 DOI: 10.1155/2020/7929610] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Bouza E, Alcalá L, Marín M, Valerio M, Reigadas E, Muñoz P, González-del Vecchio M, de Egea V. An outbreak of Clostridium difficile PCR ribotype 027 in Spain: risk factors for recurrence and a novel treatment strategy. Eur J Clin Microbiol Infect Dis 2017;36:1777-86. [DOI: 10.1007/s10096-017-2991-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]